MiNK Therapeutics Inc

NASDAQ:INKT   3:59:54 PM EDT
1.29
0.00 (0.00%)
Earnings Announcements

Mink Therapeutics Reports Q1 Loss Per Share Of $0.23

Published: 05/10/2022 12:21 GMT
MiNK Therapeutics Inc (INKT) - Q1 Loss per Share $0.23.
Per Share Losses Were $0.23 in Q1 of 2022.
Ended Q1 2022 With a Cash Balance of $34.7 Million As Compared to $38.9 Million at December 31, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.24

More details on our Analysts Page.